Indica Labs: Learn about the latest advancements in AI-powered pathology CRC Macrodissect AI and Breast HER2 AI Sneak Peek Date: 27 March 2025 Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 15:00 – 16:00...

Aiforia obtained the In Vitro Diagnostic Regulation (IVDR) certification and successfully launches three new CE-IVD marked AI solutions for breast and prostate cancer diagnostics Aiforia Technologies Plc, Press Release, February 20, 2025 at...

Aiforia selected to provide AI-assisted diagnostic solutions to regional health authorities in Italy Aiforia Technologies Plc PRESS RELEASE January 24, 2025 at 3.45 p.m. EET The Lombardy region health authorities in Italy have selected...

Nijmegen, the Netherlands –  Aiosyn, a pioneering innovator in AI-powered pathology software for cancer and kidney disease, has announced that its algorithm for mitotic figure counting has achieved CE marking under the In Vitro Diagnostic...

A study from PreciseDx showed that its artificial-intelligence-guided pathology test could help predict a patient’s chances of their breast cancer returning on par with a leading genomic approach. Working with real-world cancer data company...

PreciseDX: World-Renowned Breast Cancer Oncology and Pathology Experts to Advise Company on the Advancement of its AI-Powered PreciseBreastTM Risk of Recurrence Assessment and Product Portfolio NEW YORK, Nov. 20, 2024 /PRNewswire/...